mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
9e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
0.0005 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0006 |